Cite
HARVARD Citation
Persano, M. et al. (n.d.). 111P Identification of atezolizumab plus bevacizumab prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma: The ABE index. Immuno-oncology technology. p. . [Online].